PERIPROCEDURAL DABIGATRAN IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION

被引:2
|
作者
Khan, Saadat [1 ]
Duggal, Manoj [1 ]
Dunskis, Paula [1 ]
Bhan, Adarsh [1 ]
机构
[1] Christ Med Ctr, Oak Lawn, IL USA
关键词
D O I
10.1016/S0735-1097(13)60401-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E401 / E401
页数:1
相关论文
共 50 条
  • [21] Case Report: Catheter Ablation of Atrial Fibrillation in Patients with Dabigatran
    Stix, G.
    JOURNAL FUR KARDIOLOGIE, 2014, 21 (3-4): : 92 - 94
  • [22] Periprocedural anticoagulation in patients undergoing cryoballoon ablation for atrial fibrillation
    Dilaveris, Polychronis
    Tousoulis, Dimitris
    HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (05) : 338 - 339
  • [23] Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation
    Phan, Kevin
    Wang, Nelson
    Pison, Laurent
    Kumar, Narendra
    Hitos, Kerry
    Thomas, Stuart P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 189 : 199 - 203
  • [24] Periprocedural Dabigatran in Atrial Fibrillation Ablation: A New Kid on the Block
    Pelargonio, Gemma
    Perna, Francesco
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (08) : 866 - 868
  • [25] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [26] Can Dabigatran Be an Alternative Periprocedural Anticoagulation for Atrial Fibrillation Ablation?
    Takahashi, Naohiko
    CIRCULATION JOURNAL, 2012, 76 (10) : 2327 - 2328
  • [27] Discontinuation period and periprocedural events of novel oral anticoagulation in patients undergoing catheter ablation of atrial fibrillation
    Hirose, S.
    Miyamoto, K.
    Nakajima, I.
    Ishibashi, K.
    Okamura, H.
    Noda, T.
    Aiba, T.
    Kamakura, S.
    Kusano, K.
    EUROPEAN HEART JOURNAL, 2014, 35 : 390 - 390
  • [28] Periprocedural complication rates in respect of anticoagulation strategies in patients undergoing catheter ablation for persistent atrial fibrillation
    Gunawardene, M.
    Steven, D.
    Sultan, A.
    Schaeffer, B.
    Schreiber, D.
    Moser, J.
    Akbulak, R. Oe
    Servatius, H.
    Hoffmann, B. A.
    Willems, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 567 - 567
  • [29] Evaluation of Periprocedural Safety and Efficacy of Dabigatran, Rivaroxaban, Apixaban and Edoxaban During Catheter Ablation for Atrial Fibrillation
    Tohoku, Shota
    Hiroshima, Kenichi
    Nagashima, Michio
    Morita, Junji
    Iseda, Takahiro
    Ando, Kengo
    Ando, Kenji
    CIRCULATION, 2016, 134
  • [30] Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis
    Phan, Kevin
    Wang, Nelson
    Pison, Laurent
    Kumar, Narendra
    Hitos, Kerry
    Thomas, Stuart P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 185 : 209 - 213